Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of $1.59 billion. The enterprise value is $2.08 billion.
| Market Cap | 1.59B |
| Enterprise Value | 2.08B |
Important Dates
The next estimated earnings date is Tuesday, July 23, 2024, after market close.
| Earnings Date | Jul 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Teladoc Health has 169.59 million shares outstanding. The number of shares has increased by 2.95% in one year.
| Shares Outstanding | 169.59M |
| Shares Change (YoY) | +2.95% |
| Shares Change (QoQ) | +1.00% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 75.99% |
| Float | 167.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 357.14 |
| PS Ratio | 0.61 |
| Forward PS | 0.58 |
| PB Ratio | 0.70 |
| P/FCF Ratio | 7.99 |
| PEG Ratio | -1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.16, with an EV/FCF ratio of 10.40.
| EV / Earnings | n/a |
| EV / Sales | 0.79 |
| EV / EBITDA | 12.16 |
| EV / EBIT | n/a |
| EV / FCF | 10.40 |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.69.
| Current Ratio | 3.82 |
| Quick Ratio | 3.37 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 9.25 |
| Debt / FCF | 7.92 |
| Interest Coverage | -9.16 |
Financial Efficiency
Return on equity (ROE) is -10.10% and return on invested capital (ROIC) is -6.68%.
| Return on Equity (ROE) | -10.10% |
| Return on Assets (ROA) | -5.40% |
| Return on Capital (ROIC) | -6.68% |
| Revenue Per Employee | $467,733 |
| Profits Per Employee | -$41,612 |
| Employee Count | 5,600 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 19.58 |
Taxes
In the past 12 months, Teladoc Health has paid $2.77 million in taxes.
| Income Tax | 2.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.30% in the last 52 weeks. The beta is 0.99, so Teladoc Health's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -63.30% |
| 50-Day Moving Average | 11.52 |
| 200-Day Moving Average | 16.36 |
| Relative Strength Index (RSI) | 33.00 |
| Average Volume (20 Days) | 7,028,589 |
Short Selling Information
The latest short interest is 27.06 million, so 15.96% of the outstanding shares have been sold short.
| Short Interest | 27.06M |
| Short Previous Month | 27.04M |
| Short % of Shares Out | 15.96% |
| Short % of Float | 16.11% |
| Short Ratio (days to cover) | 6.34 |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.62 billion and -$233.03 million in losses. Loss per share was -$1.41.
| Revenue | 2.62B |
| Gross Profit | 1.85B |
| Operating Income | -258.57M |
| Pretax Income | -230.26M |
| Net Income | -233.03M |
| EBITDA | 170.72M |
| EBIT | -207.59M |
| Loss Per Share | -$1.41 |
Balance Sheet
The company has $1.10 billion in cash and $1.58 billion in debt, giving a net cash position of -$481.58 million or -$2.84 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 1.58B |
| Net Cash | -481.58M |
| Net Cash Per Share | -$2.84 |
| Equity (Book Value) | 2.29B |
| Book Value Per Share | 13.50 |
| Working Capital | 1.10B |
Cash Flow
In the last 12 months, operating cash flow was $345.79 million and capital expenditures -$146.24 million, giving a free cash flow of $199.55 million.
| Operating Cash Flow | 345.79M |
| Capital Expenditures | -146.24M |
| Free Cash Flow | 199.55M |
| FCF Per Share | $1.19 |
Margins
Gross margin is 70.81%, with operating and profit margins of -9.87% and -8.90%.
| Gross Margin | 70.81% |
| Operating Margin | -9.87% |
| Pretax Margin | -8.79% |
| Profit Margin | -8.90% |
| EBITDA Margin | 6.52% |
| EBIT Margin | -7.93% |
| FCF Margin | 7.62% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.95% |
| Shareholder Yield | -2.95% |
| Earnings Yield | -14.62% |
| FCF Yield | 12.52% |
Analyst Forecast
The average price target for Teladoc Health is $19.56, which is 108.09% higher than the current price. The consensus rating is "Hold".
| Price Target | $19.56 |
| Price Target Difference | 108.09% |
| Analyst Consensus | Hold |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 4.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -3.74 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.74 |
| Piotroski F-Score | 6 |